Thompson Siegel & Walmsley’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-13,312
Closed -$641K 793
2019
Q2
$641K Sell
13,312
-2,013
-13% -$106K 0.01% 307
2019
Q1
$960K Sell
15,325
-31,999
-68% -$2.2M 0.01% 275
2018
Q4
$2.83M Sell
47,324
-28,901
-38% -$1.74M 0.04% 180
2018
Q3
$4.91M Sell
76,225
-74,870
-50% -$4.18M 0.06% 175
2018
Q2
$6.8M Sell
151,095
-266,785
-64% -$10.6M 0.09% 157
2018
Q1
$13M Sell
417,880
-121,063
-22% -$3.98M 0.16% 135
2017
Q4
$16.1M Buy
538,943
+836
+0.2% +$24.2K 0.19% 126
2017
Q3
$17.8M Buy
538,107
+105,345
+24% +$3.65M 0.21% 126
2017
Q2
$14.5M Buy
432,762
+9,493
+2% +$283K 0.17% 147
2017
Q1
$12.3M Sell
423,269
-236,151
-36% -$5.85M 0.14% 176
2016
Q4
$14.7M Sell
659,420
-200,630
-23% -$3.92M 0.19% 145
2016
Q3
$16M Sell
860,050
-168,594
-16% -$3.18M 0.25% 137
2016
Q2
$16.8M Sell
1,028,644
-542
-0.1% -$7.97K 0.26% 122
2016
Q1
$12M Sell
1,029,186
-18,167
-2% -$203K 0.2% 170
2015
Q4
$12.2M Buy
+1,047,353
New +$13.3M 0.22% 163

Other funds holding BEAT

Thompson Siegel & Walmsley's BEAT Position: Q3 2019 in Review

Thompson Siegel & Walmsley sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 13,312 shares — an estimated $641K sold.

Thompson Siegel & Walmsley first reported a position in BEAT in Q4 2015 and held it in 15 quarters. The position peaked at $17.8M in Q3 2017. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Thompson Siegel & Walmsley reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 13,312 BioTelemetry, Inc. shares in Q3 2019, an estimated $641K.
  • Thompson Siegel & Walmsley first reported a position in BioTelemetry, Inc. in Q4 2015 and held it in 15 quarters.
  • Thompson Siegel & Walmsley's BioTelemetry, Inc. position peaked at $17.8M in Q3 2017.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2019, filed 12 Nov 2019.